Clara O Sailer Selected Research

dulaglutide

2/2024	Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial.
3/2023	Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial.
1/2022	Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
10/2021	A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clara O Sailer Research Topics

Disease

8	Psychogenic Polydipsia 03/2024 - 01/2018
6	Hyponatremia 01/2023 - 01/2019
2	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 03/2024 - 01/2023
2	Weight Gain 02/2024 - 03/2023
2	Polyuria 11/2023 - 01/2019
2	Autonomic Dysreflexia 01/2023 - 01/2022
2	Pneumonia (Pneumonitis) 01/2023 - 01/2022
2	Diabetes Insipidus 10/2020 - 01/2019
1	Tobacco Use Disorder (Nicotine Dependence) 02/2024
1	Polydipsia 11/2023
1	Pituitary Diseases (Disease, Anterior Pituitary) 01/2023
1	Body Weight (Weight, Body) 01/2022
1	Hypopituitarism (Sheehan's Syndrome) 08/2021
1	Hypernatremia 03/2021
1	Hypotension (Low Blood Pressure) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2019

Drug/Important Bio-Agent (IBA)

4	Arginine Vasopressin (Argipressin)IBA 03/2024 - 10/2020
4	dulaglutideIBA 02/2024 - 10/2021
3	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2024 - 11/2020
3	empagliflozinIBA 01/2023 - 01/2020
2	Arginine (L-Arginine)FDA Link 11/2023 - 01/2019
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2023 - 08/2021
2	Sodium Chloride FDA LinkGeneric 01/2022 - 10/2021
2	ElectrolytesIBA 01/2020 - 01/2019
1	Varenicline (Chantix)FDA Link 02/2024
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2023
1	Vasopressins (Vasopressin)IBA 12/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	AlbuminsIBA 01/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Hypnotics and Sedatives (Sedatives)IBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2021
1	Growth Hormone (Somatotropin)IBA 01/2019
1	SodiumIBA 01/2019
1	DiureticsIBA 01/2019

Therapy/Procedure

2	Therapeutics 02/2024 - 01/2018
1	Duration of Therapy 02/2024
1	Length of Stay 01/2022
1	Subcutaneous Injections 01/2022
1	Artificial Respiration (Mechanical Ventilation) 03/2021